Tesofensine 500mcg 100ct Research Capsule

TESOFENSINE – 500MCG (100 TABLETS)

Research Use Only | Not for Human Consumption

Product Overview

Tesofensine is a triple monoamine reuptake inhibitor (SNDRI) that modulates key neurotransmitters in the brain—dopamine, serotonin, and norepinephrine.

It is currently being studied in laboratory and clinical research settings for its potential role in metabolic regulation, appetite signaling, and energy balance pathways.

Mechanism of Action (Research Context)

Tesofensine works by inhibiting the reuptake of:

Dopamine (DA)

Serotonin (5-HT)

Norepinephrine (NE)

This leads to increased availability of these neurotransmitters, which are associated with:

Appetite regulation

Reward signaling

Energy expenditure

Research Applications

Tesofensine has been explored in studies involving:

Metabolic and obesity research models

Appetite suppression pathways

Neurotransmitter interaction studies

Energy expenditure and weight regulation mechanisms

Preclinical and clinical data suggest it may:

Reduce food intake

Influence metabolic activity

Support sustained weight reduction in research settings

Key Research Insights

Demonstrated significant weight reduction effects in controlled trials

May impact both appetite and metabolic rate

Long half-life allows for extended activity in study models

Product Specifications

Compound: Tesofensine

Dosage: 500mcg per tablet

Quantity: 100 Tablets

Form: Oral tablet (research format)

Important Notice

For laboratory research use only

Not for human or animal consumption

Not intended to diagnose, treat, cure, or prevent any disease